Fertilix Supplements and Assisted Reproductive Technology

Withdrawn before enrolling · Not applicable · Has a placebo group

Conditions studied: Spermatozoa

In brief

This is a double blind, randomized, placebo controlled clinical trial to test the efficacy of the antioxidant formulation Fertilix® in lowering the levels of damaged sperm DNA in men diagnosed with moderate to high Sperm Oxidative DNA Damage (SODD)

Key facts

Study ID
NCT02621125
Run by
University Reproductive Associates
People needed
0
Starts
2016-02-01
Expected to finish
2016-02-01
Last updated by the study team
2017-05-02

Who can join

Age: 20 and older, up to 55. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.